Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZYTIGA for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where ZYTIGA was used for Neoplasm malignant.

Most Reported Side Effects for ZYTIGA

Side Effect Reports % Deaths Hosp.
Death 73 16.9% 73 8
Disease progression 31 7.2% 23 4
Prostatic specific antigen increased 27 6.3% 8 6
Blood alkaline phosphatase increased 19 4.4% 12 2
Drug ineffective 19 4.4% 3 2
Asthenia 17 3.9% 4 9
Fatigue 17 3.9% 3 8
Anaemia 15 3.5% 2 10
Haemoglobin decreased 12 2.8% 11 0
Pain 12 2.8% 3 7
Prostate cancer 12 2.8% 9 4
Urinary tract infection 12 2.8% 3 7
Atrial fibrillation 11 2.6% 3 6
Hypokalaemia 11 2.6% 3 8
Pneumonia 11 2.6% 3 9

Other Indications for ZYTIGA

Prostate cancer (219) Product used for unknown indication (99) Prostate cancer metastatic (68)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

ZYTIGA Full Profile All Neoplasm malignant Drugs ZYTIGA Demographics ZYTIGA Timeline